Cytodyn Inc (CYDY)

[fred198484]

I guess what we don't know is how fast they are recruiting patients right now. Perhaps they will have enough by the time they meet with the FDA. By relaxing the MAraviroc requirement and by adding the use of non-approved drugs to the optimized background regimen, they may be able to add patients much faster than in the past. But the more patients they have the more money they need. So, we still await a PR on the fundraising that is either already happening or about to be announced. We need to get that out of the way and now we need to find out what the FDA and company can agree upon regarding their study. I imagine this will not be available on 10/12 as the FDA will likely take the company's feedback and evaluate it before issuing some sort of guidance about the combo trial and maybe mono too, who knows?